PU
PURE Bioscience, Inc.
PURE · OTC
$0.07 -17.79% (-$0.01)
1M +29.97%
Market Cap $10.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.09
37.2% upside
Trenutna cena
$0.066
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PURE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
3 /100
Expensive P/S 4.28x
EV/EBITDA 85.89x
P/FFO N/A
Growth
65 /100
Stable Rev. growth 5.92%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 79.11%
Gross margin 53,803.60%
FCF margin 73.49%
Quality
21 /100
Poor Asset turnover 1.55x
ROIC 291.19%
ROA 141.53%
Debt
0 /100
High Net debt/EBITDA 29.81x
Current ratio 0.42x
Int. coverage -0.01x
Stability
62 /100
Moderate EPS volatility 9.55%
Beta 0.23x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PURE
Online
Sector
Basic Materials
Industry
Chemicals
CEO
Jeff Kitchell
Employees
12
Headquarters
El Cajon